NEW YORK (TheStreet) -- RATINGS CHANGES
Allergan (AGN) was upgraded at Leerink Swann to outperform from market perform. Risk/reward is compelling, following a significant pullback in the stock, Leerink Swann said. Twelve-month price target is $184.
ANN (ANN) was downgraded at UBS to neutral. Twelve-month price target was changed to to $37, based on lower visibility for top-line drivers, UBS said.
Avis Budget (CAR) was upgraded to buy at TheStreet Ratings.
CST Brands (CST) was upgraded at Credit Suisse to neutral. Company can deliver solid growth, Credit Suisse said. Twelve-month price target was raised to $35.
Delek US (DK) was upgraded at Cowen to outperform from market perform. Twelve-month price target is $43. Company is attractively valued, on a sum-of-the-parts basis, Cowen said.
Hibbett Sports (HIBB) was downgraded at Sterne Agee to neutral. Poor store traffic is weighing on sales, Sterne Agee said.
Hibbett Sports was downgraded at BMO to market perform. Second-quarter earnings came in short of expectations, BMO said. Twelve-month price target was lowered to $52.
Hibbett Sports was downgraded at Credit Suisse to underperform from neutral. Twelve-month price target is $42. Company has an uncertain outlook, Credit Suisse said.
John Bean Technologies (JBT) was upgraded to buy at TheStreet Ratings.
Nvidia (NVDA) was upgraded at Needham to buy from hold. Twelve-month price target is $23. Company is going through a fundamental transformation and expanding margins, Needham said.
Pozen (POZN) was upgraded at Ascendiant Capital to buy. Company is seeing higher licensing and royalty revenue, Ascendiant Capital said.